{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T23:52:11Z","timestamp":1792713131852,"version":"4.5.0"},"reference-count":78,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":6342,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1111\/j.1538-7836.2005.01369.x","type":"journal-article","created":{"date-parts":[[2005,8,8]],"date-time":"2005-08-08T04:34:38Z","timestamp":1123475678000},"page":"1702-1709","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":146,"title":["von Willebrand factor: two sides of a coin"],"prefix":"10.1016","volume":"3","author":[{"given":"J.E.","family":"SADLER","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0010","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev.cb.06.110190.001245","article-title":"Cell biology of von Willebrand factor","volume":"6","author":"Wagner","year":"1990","journal-title":"Annu Rev Cell Biol"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0015","doi-asserted-by":"crossref","first-page":"49982","DOI":"10.1074\/jbc.M408727200","article-title":"A covalent oxidoreductase intermediate in propeptide\u2010dependent von Willebrand factor multimerization","volume":"279","author":"Purvis","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0020","doi-asserted-by":"crossref","first-page":"13497","DOI":"10.1016\/S0021-9258(18)80024-2","article-title":"In vitro multimerization of von Willebrand factor is triggered by low pH. Importance of the propolypeptide and free sulfhydryls","volume":"264","author":"Mayadas","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0025","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1365-2516.1998.0040s3033.x","article-title":"Pharmacokinetics, efficacy and safety of Humate\u2010P in von Willebrand disease","volume":"4","author":"Dobrkovska","year":"1998","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0030","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1046\/j.1365-2141.1996.d01-1860.x","article-title":"Pharmacokinetics of von Willebrand factor and factor VIIIC in patients with severe von Willebrand disease (type 3 VWD): estimation of the rate of factor VIIIC synthesis","volume":"94","author":"Menache","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0035","doi-asserted-by":"crossref","first-page":"12102","DOI":"10.1074\/jbc.M310436200","article-title":"An experimental model to study the in vivo survival of von Willebrand factor. Basic aspects and application to the R1205H mutation","volume":"279","author":"Lenting","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0040","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1182\/blood.V83.8.2171.2171","article-title":"Shear stress enhances the proteolysis of von Willebrand factor in normal plasma","volume":"83","author":"Tsai","year":"1994","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0045","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1182\/blood.V87.10.4223.bloodjournal87104223","article-title":"Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis","volume":"87","author":"Furlan","year":"1996","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0050","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1182\/blood.V87.10.4235.bloodjournal87104235","article-title":"Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion","volume":"87","author":"Tsai","year":"1996","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0055","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1172\/JCI115376","article-title":"Heterogeneity of plasma von Willebrand factor multimers resulting from proteolysis of the constituent subunit","volume":"88","author":"Dent","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0060","doi-asserted-by":"crossref","first-page":"7503","DOI":"10.1073\/pnas.90.16.7503","article-title":"Triplet structure of von Willebrand factor reflects proteolytic degradation of high molecular weight multimers","volume":"90","author":"Furlan","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0065","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1182\/blood.V98.6.1662","article-title":"Purification of human von Willebrand factor\u2010cleaving protease and its identification as a new member of the metalloproteinase family","volume":"98","author":"Fujikawa","year":"2001","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0070","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1182\/blood.V98.6.1654","article-title":"Partial amino acid sequence of purified von Willebrand factor\u2010cleaving protease","volume":"98","author":"Gerritsen","year":"2001","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0075","doi-asserted-by":"crossref","first-page":"41059","DOI":"10.1074\/jbc.C100515200","article-title":"Structure of von Willebrand factor\u2010cleaving protease (ADAMTS\u201013), a metalloprotease involved in thrombotic thrombocytopenic purpura","volume":"276","author":"Zheng","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0080","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/35097008","article-title":"Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura","volume":"413","author":"Levy","year":"2001","journal-title":"Nature"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0085","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/oxfordjournals.jbchem.a003009","article-title":"A novel human metalloprotease synthesized in the liver and secreted into the blood: possibly, the von Willebrand factor\u2010cleaving protease","volume":"130","author":"Soejima","year":"2001","journal-title":"J Biochem"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0090","doi-asserted-by":"crossref","first-page":"11552","DOI":"10.1073\/pnas.192448999","article-title":"A new name in thrombosis, ADAMTS\u201013","volume":"99","author":"Sadler","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0095","doi-asserted-by":"crossref","first-page":"11902","DOI":"10.1073\/pnas.172277399","article-title":"Mutations and common polymorphisms in ADAMTS\u201013 gene responsible for von Willebrand factor\u2010cleaving protease activity","volume":"99","author":"Kokame","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0100","doi-asserted-by":"crossref","first-page":"30136","DOI":"10.1074\/jbc.M305331200","article-title":"Cleavage of von Willebrand factor requires the spacer domain of the metalloprotease ADAMTS\u201013","volume":"278","author":"Zheng","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0105","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1182\/blood-2003-03-0908","article-title":"ADAMTS\u201013 cysteine\u2010rich\/spacer domains are functionally essential for von Willebrand factor cleavage","volume":"102","author":"Soejima","year":"2003","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0110","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1182\/blood-2003-08-2861","article-title":"VWF73, a region from D1596 to R1668 of von Willebrand factor, provides a minimal substrate for ADAMTS\u201013","volume":"103","author":"Kokame","year":"2004","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0115","doi-asserted-by":"crossref","first-page":"10578","DOI":"10.1073\/pnas.0402041101","article-title":"Binding of platelet glycoprotein Ib\u03b1 to von Willebrand factor domain A1 stimulates the cleavage of the adjacent domain A2 by ADAMTS\u201013","volume":"101","author":"Nishio","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0120","doi-asserted-by":"crossref","first-page":"29633","DOI":"10.1074\/jbc.M301385200","article-title":"ADAMTS\u201013 metalloprotease interacts with the endothelial cell\u2010derived ultra\u2010large von Willebrand factor","volume":"278","author":"Dong","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0125","doi-asserted-by":"crossref","first-page":"150a","DOI":"10.1182\/blood.V104.11.515.515","article-title":"Characterization of the binding interaction between ADAMTS\u201013 and von Willebrand factor (VWF)","volume":"104","author":"Majerus","year":"2004","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0130","doi-asserted-by":"crossref","first-page":"39a","DOI":"10.1182\/blood.V104.11.126.126","article-title":"ADAMTS\u201013 binds VWF via its C\u2010terminal CUB2 domain","volume":"104","author":"Zhang","year":"2004","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0135","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1016\/S0021-9258(18)42852-9","article-title":"Impaired intracellular transport produced by a subset of type IIA von Willebrand disease mutations","volume":"267","author":"Lyons","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0140","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1172\/JCI112394","article-title":"Subunit composition of plasma von Willebrand factor. Cleavage is present in normal individuals, increased in IIA and IIB von Willebrand disease, but minimal in variants with aberrant structure of individual oligomers (types IIC, IID, and IIE)","volume":"77","author":"Zimmerman","year":"1986","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0145","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1182\/blood.V84.4.1024.1024","article-title":"Characterization of von Willebrand factor gene defects in two unrelated patients with type IIC von Willebrand disease","volume":"84","author":"Gaucher","year":"1994","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0150","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/BF00209487","article-title":"Identification of a candidate missense mutation in a family with von Willebrand disease type IIC","volume":"95","author":"Schneppenheim","year":"1995","journal-title":"Hum Genet"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0155","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1172\/JCI110700","article-title":"Aberrant multimeric structure of von Willebrand factor in a new variant of von Willebrand's disease (type IIC)","volume":"70","author":"Ruggeri","year":"1982","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0160","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1053\/beha.2001.0134","article-title":"A molecular approach to the classification of von Willebrand disease","volume":"14","author":"Schneppenheim","year":"2001","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0165","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1073\/pnas.93.8.3581","article-title":"Defective dimerization of von Willebrand factor subunits due to a Cys \u00d8 Arg mutation in type IID von Willebrand disease","volume":"93","author":"Schneppenheim","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0170","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1182\/blood.V63.6.1369.1369","article-title":"A new variant of dominant type II von Willebrand's disease with aberrant multimeric pattern of factor VIII\u2010related antigen (type IID)","volume":"63","author":"Kinoshita","year":"1984","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0175","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1182\/blood.V83.6.1551.1551","article-title":"Characterization of Leu777Pro and Ile865Thr type IIA von Willebrand disease mutations","volume":"83","author":"Lyons","year":"1994","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0180","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1182\/blood.V89.6.1954","article-title":"Proteolytic cleavage of recombinant type 2A von Willebrand factor mutants R834W and R834Q: inhibition by doxycycline and by monoclonal antibody VP\u20101","volume":"89","author":"Tsai","year":"1997","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0185","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00894-004-0194-9","article-title":"Molecular modeling of the von Willebrand factor A2 Domain and the effects of associated type 2A von Willebrand disease mutations","volume":"10","author":"Sutherland","year":"2004","journal-title":"J Mol Model (Online)"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0190","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1056\/NEJM198005083021902","article-title":"Heightened interaction between platelets and factor VIII\/von Willebrand factor in a new subtype of von Willebrand's disease","volume":"302","author":"Ruggeri","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0195","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1182\/blood.V89.9.3097","article-title":"Deficient activity of von Willebrand factor\u2010cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura","volume":"89","author":"Furlan","year":"1997","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0200","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1182\/blood.V91.8.2839.2839_2839_2846","article-title":"Acquired deficiency of von Willebrand factor\u2010cleaving protease in a patient with thrombotic thrombocytopenic purpura","volume":"91","author":"Furlan","year":"1998","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0205","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1056\/NEJM199811263392203","article-title":"Antibodies to von Willebrand factor\u2010cleaving protease in acute thrombotic thrombocytopenic purpura","volume":"339","author":"Tsai","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0210","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1182\/blood.V60.6.1453.1453","article-title":"Type IIB von Willebrand's disease: differential clearance of endogenous versus transfused large multimer von willebrand factor","volume":"60","author":"Ruggeri","year":"1982","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0215","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1182\/blood.V59.6.1272.1272","article-title":"Multimeric composition of factor VIII\/von Willebrand factor following administration of DDAVP: implications for pathophysiology and therapy of von Willebrand's disease subtypes","volume":"59","author":"Ruggeri","year":"1982","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0220","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1182\/blood.V89.8.2766","article-title":"Functional studies on platelet adhesion with recombinant von Willebrand factor type 2B mutants R543Q and R543W under conditions of flow","volume":"89","author":"Lankhof","year":"1997","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0225","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1056\/NEJM198310063091402","article-title":"Platelet aggregation induced by 1\u2010desamino\u20108\u2010d\u2010arginine vasopressin (DDAVP) in Type IIB von Willebrand's disease","volume":"309","author":"Holmberg","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0230","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1055\/s-0037-1614447","article-title":"Post\u2010DDAVP thrombocytopenia in type 2B von Willebrand disease is not associated with platelet consumption: failure to demonstrate glycocalicin increase or platelet activation","volume":"81","author":"Casonato","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0235","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/00043426-198624000-00010","article-title":"Factor VIII concentrate\u2010responsive thrombocytopenia, hemolytic anemia, and nephropathy. Evidence that factor VIII:von Willebrand factor is involved in its pathogenesis","volume":"8","author":"Hara","year":"1986","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0240","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1182\/blood.V88.7.2433.bloodjournal8872433","article-title":"Dominant type 1 von Willebrand disease caused by mutated cysteine residues in the D3 domain of von Willebrand factor","volume":"88","author":"Eikenboom","year":"1996","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0245","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1182\/blood.V98.10.2973","article-title":"Type 1 von Willebrand disease mutation Cys1149Arg causes intracellular retention and degradation of heterodimers: a possible general mechanism for dominant mutations of oligomeric proteins","volume":"98","author":"Bod\u00f3","year":"2001","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0250","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1538-7836.2003.00435.x","article-title":"Dimerization and multimerization defects of von Willebrand factor due to mutated cysteine residues","volume":"2","author":"Tjernberg","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0255","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1055\/s-0037-1613232","article-title":"Von Willebrand's disease caused by compound heterozygosity for a substitution mutation (T1156M) in the D3 domain of the von Willebrand factor and a stop mutation (Q2470X)","volume":"88","author":"Lethagen","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0260","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1182\/blood.V99.11.4243","article-title":"The elusive pathogenesis of von Willebrand disease Vicenza","volume":"99","author":"Castaman","year":"2002","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0265","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1046\/j.1538-7836.2003.00359.x","article-title":"Increased clearance of von Willebrand factor antigen post\u2010DDAVP in Type 1 von Willebrand disease: is it a potential pathogenic process?","volume":"1","author":"Brown","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0270","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1600-0609.1988.tb00815.x","article-title":"Hyper\u2010responsiveness to DDAVP for patients with type I von Willebrand's disease and normal intra\u2010platelet von Willebrand factor","volume":"40","author":"Rodeghiero","year":"1988","journal-title":"Eur J Haematol"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0275","first-page":"128a","article-title":"A mutation in the D4 domain of von Willebrand factor (VWF) results in a variant of type 1 von Willebrand disease with accelerated in vivo VWF clearance","volume":"100","author":"Gavazova","year":"2002","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0280","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1182\/blood.V71.1.65.65","article-title":"Willebrand disease \u2018Vicenza\u2019 with larger\u2010than\u2010normal (supranormal) von Willebrand factor multimers","volume":"71","author":"Mannucci","year":"1988","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0285","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1055\/s-0037-1613769","article-title":"Von Willebrand Disease type 2M \u2018Vicenza\u2019 in Italian and German patients: identification of the first candidate mutation (G3864A; R1205H) in 8 families","volume":"83","author":"Schneppenheim","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0290","doi-asserted-by":"crossref","first-page":"998a","DOI":"10.1182\/blood.V104.11.3669.3669","article-title":"Increased clearance explains the ultra\u2010large multimers in von Willebrand disease type 2M Vicenza; lessons from recombinant VWF Vicenza and modeling of multimer catabolism","volume":"104","author":"G\u00e9zsi","year":"2004","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0295","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1182\/blood.V99.1.180","article-title":"Willebrand factor survival in type Vicenza von Willebrand disease","volume":"99","author":"Casonato","year":"2002","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0300","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1309\/75CQ-V7UX-4QX8-WXE7","article-title":"Quantification and facilitated comparison of von Willebrand factor multimer patterns by densitometry","volume":"116","author":"Studt","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0305","first-page":"P1805","article-title":"The first mutations in von Willebrand disease type IIC Miami","author":"Schneppenheim","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0310","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1182\/blood.V82.1.169.bloodjournal821169","article-title":"New variant of von Willebrand disease type II with markedly increased levels of von Willebrand factor antigen and dominant mode of inheritance: von Willebrand disease type IIC Miami","volume":"82","author":"Ledford","year":"1993","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0315","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1182\/blood.V69.6.1691.1691","article-title":"The effect of ABO blood group on the diagnosis of von Willebrand disease","volume":"69","author":"Gill","year":"1987","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0320","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1182\/blood.V74.7.2433.2433","article-title":"Heterogeneous phenotypes of platelet and plasma von Willebrand factor in obligatory heterozygotes for severe von Willebrand disease","volume":"74","author":"Mannucci","year":"1989","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0325","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1182\/blood-2002-09-2892","article-title":"Von Willebrand disease type 1: a diagnosis in search of a disease","volume":"101","author":"Sadler","year":"2003","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0330","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1146\/annurev.med.56.082103.104713","article-title":"New concepts in von Willebrand disease","volume":"56","author":"Sadler","year":"2005","journal-title":"Annu Rev Med"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0335","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1161\/01.STR.0000119382.25543.2A","article-title":"Hemostatic factors as risk markers for intracerebral hemorrhage: a prospective incident case\u2010referent study","volume":"35","author":"Johansson","year":"2004","journal-title":"Stroke"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0340","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1161\/01.CIR.0000077912.12202.FC","article-title":"Prognostic value of plasma von Willebrand factor and soluble P\u2010selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation","volume":"107","author":"Conway","year":"2003","journal-title":"Circulation"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0345","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1161\/01.ATV.19.12.3071","article-title":"von Willebrand factor, C\u2010reactive protein, and 5\u2010year mortality in diabetic and nondiabetic subjects: the Hoorn Study","volume":"19","author":"Jager","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0350","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1053\/euhj.2001.3237","article-title":"von Willebrand factor and coronary heart disease: prospective study and meta\u2010analysis","volume":"23","author":"Whincup","year":"2002","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0355","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1161\/01.CIR.0000120705.55512.EC","article-title":"Endothelial cell markers and the risk of coronary heart disease: the prospective epidemiological study of myocardial infarction (PRIME) study","volume":"109","author":"Morange","year":"2004","journal-title":"Circulation"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0360","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0140-6736(95)90166-3","article-title":"Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep\u2010vein thrombosis","volume":"345","author":"Koster","year":"1995","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0365","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S0002-9343(02)01345-1","article-title":"Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE)","volume":"113","author":"Tsai","year":"2002","journal-title":"Am J Med"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0370","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1046\/j.1365-2141.2000.01944.x","article-title":"Autosomal dominant type 1 von willebrand disease due to G3639T mutation (C1130F) in exon 26 of von Willebrand factor gene: description of five Italian families and evidence for a founder effect","volume":"108","author":"Castaman","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0375","first-page":"89a","article-title":"The spectrum of phenotype\/genotype associations in type 1 von Willebrand disease: results from the Canadian type 1 VWD study","volume":"102","author":"James","year":"2003","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0380","first-page":"90a","article-title":"Analysis of cosegregation of type 1 von Willebrands disease phenotype and von Willebrand factor gene haplotypes in the European multicenter MCMDM\u20101VWD study","volume":"102","author":"Eikenboom","year":"2003","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0385","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1182\/blood.V54.1.117.117","article-title":"Genetics of classic von Willebrand's disease. I. Phenotypic variation within families","volume":"54","author":"Miller","year":"1979","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0390","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1055\/s-0037-1614330","article-title":"Inconsistency of association between type 1 von Willebrand Disease phenotype and genotype in families identified in an epidemiological investigation","volume":"82","author":"Castaman","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2005.01369.x_bb0395","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1046\/j.1365-2141.2001.03132.x","article-title":"Significant linkage and non\u2010linkage of type 1 von Willebrand disease to the von Willebrand factor gene","volume":"115","author":"Casa\u00f1a","year":"2001","journal-title":"Br J Haematol"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2005.01369.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622162999?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622162999?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2005.01369.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:35:30Z","timestamp":1761532530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622162999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":78,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["S1538783622162999"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2005.01369.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2005,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"von Willebrand factor: two sides of a coin","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2005.01369.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}